SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Vitamin Shoppe, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the July 8, 2013 Lead Plaintiff

STEVENSON, Md., May 8, 2013 (GLOBE NEWSWIRE) -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Vitamin Shoppe, Inc. ("Vitamin Shoppe" or the "Company") (NYSE:VSI) common stock during the period between May 8, 2012 and February 25, 2013, inclusive (the "Class Period").

If you have suffered a net loss from investment in Vitamin Shoppe, Inc. common stock purchased on or after May 8, 2012, and held through February 25, 2013, you may obtain additional information about this lawsuit and your ability to become a lead plaintiff by contacting Brower Piven at, by email at, by calling 410/415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and class action cases of over 60 years.

No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff no later than July 8, 2013 and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement and how much of a settlement to accept for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the Company during the Class Period.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants' failure to disclose during the Class Period that the Company was being negatively impacted by significant price reductions on popular supplements by competing on-line retailers and by GNC's new discount program and that the Company was experiencing declining same-store sales trends. According to the Complaint, following Vitamin Shoppe's February 25, 2013 disclosure of lackluster financial results for the Company's fiscal year and fourth quarter 2012, including the disclosure that same-store sales growth had plummeted, the value of Vitamin Shoppe shares declined significantly.

Brower Piven had previously been investigating Vitamin Shoppe for potential violations of the federal securities laws. The investigation of Vitamin Shoppe was related to whether the Company had adequately disclosed the impact competition from on-line retailers and others was having on its same-store sales.

If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

CONTACT: Charles J. Piven Brower Piven, A Professional Corporation Stevenson, Maryland 410/415-6616 hoffman@browerpiven.comSource: Brower Piven, A Professional Corporation